Funded Tech Companies
Quell Therapeutics
Quell Therapeutics is a biopharmaceutical company, based in London. Venture capital investment was provided by Fidelity Management & Research Company, Tekla Capital Management and JEITO.
Company Overview
Company Name
Quell Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Translation & Innovation Hub 84 Wood Ln.
London, W12 OBZ
UK
London, W12 OBZ
UK
Phone
Website
Email Address
Company Background Information
Overview
At Quell we seek to deliver truly innovative, life-changing therapies for our patients. Our vision as a company is to build a major global biopharmaceutical company bringing transformational and valued therapies for a range of autoimmune and inflammatory diseases, as well as preventing rejection in organ transplantation, based on modular engineered Tregs.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/30/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Iain McGill
Chief Medical Officer
Dominik Hartl
Chief Scientific Officer
Tracey Lodie
Founder
Elmar Jaeckel
Founder
Giovanna Lombardi
Founder
Emma Morris
Founder
Hans Stauss
Vice President
Jodie Albutt
Vice President
Marc Martinez-Llordella
VP - Bus. Development
Luke Henry
VP - Finance
Mark Fox
VP - Product Management
Bernd Schmidt
VP - R & D
Nathalie Belmonte
Company Investors
- Fidelity Management & Research Company
- Tekla Capital Management
- JEITO (Rachel Mears)
- Syncona (Martin Murphy)
- Point72 Ventures
- British Patient Capital
- SV Health Investors (Houman Ashrafian)
- Ridgeback Capital (Jeffrey Long-McGie)
- Monashee Investment Management
- Janus Henderson Investors
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs